Integrin α3β1 as a breast cancer target

Bibliography

• Alvarez RH. Present and future evolution of advanced breast cancer therapy. Breast Cancer Res 2010;12(Suppl 2):S1
   PubMedGoogle Scholar
• Weiner LM. Building better magic bullets-improving unconjugated monoclonal antibody therapy for cancer. Nat Rev Cancer 2007;7:701-6
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-42
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Leyland-Jones B, Shak S, Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-92
   PubMed Web of Science ®Google Scholar
• Brackstone M, Townson JL, Chambers AF. Tumour dormancy in breast cancer: an update. Breast Cancer Res 2007;9:208-14
   Google Scholar
• Kiely BE, Soon YY, Tattersall MH, Stockler MR. How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials. J Clin Oncol 2011;29:456-63
   PubMed Web of Science ®Google Scholar
• Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002;110:673-87
   PubMed Web of Science ®Google Scholar
• Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10:9-22
   PubMed Web of Science ®Google Scholar
• Kass L, Erler JT, Dembo M, Weaver VM. Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis. Int J Biochem Cell Biol 2007;39:1987-94
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Schwartz MA, Burridge K, Cell migration: integrating signals from front to back. Science 2003;302:1704-9
   PubMed Web of Science ®Google Scholar
• Delon I, Brown NH. Integrins and the actin cytoskeleton. Curr Opin Cell Biol 2007;19:43-50
   PubMed Web of Science ®Google Scholar
• Brakebusch C, Bouvard D, Stanchi F, Integrins in invasive growth. J Clin Invest 2002;109:999-1006
   PubMed Web of Science ®Google Scholar
• Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-26
   PubMed Web of Science ®Google Scholar
• Stupp R, Ruegg C. Integrin inhibitors reaching the clinic. J Clin Oncol 2007;25:1637-8
   PubMed Web of Science ®Google Scholar
• Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 2002;4:E65-8
   PubMed Web of Science ®Google Scholar
• Playford MP, Schaller MD. The interplay between Src and integrins in normal and tumor biology. Oncogene 2004;23:7928-46
   PubMed Web of Science ®Google Scholar
• Brunton VG, Frame MC. Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 2008;8:427-32
   PubMed Web of Science ®Google Scholar
• Guan JL. Integrin signaling through FAK in the regulation of mammary stem cells and breast cancer. IUBMB Life 2010;62:268-76
   PubMed Web of Science ®Google Scholar
• Choma DP, Milano V, Pumiglia KM, DiPersio CM. Integrin alpha3beta1-dependent activation of FAK/Src regulates Rac1-mediated keratinocyte polarization on laminin-5. J Invest Dermatol 2007;127:31-40
   PubMedGoogle Scholar
• Raymond K, Cagnet S, Kreft M, Control of mammary myoepithelial cell contractile function by alpha3beta1 integrin signalling. EMBO J 2011;30:1896-906
   Google Scholar
• Chapman HA, Wei Y, Simon DI, Waltz DA. Role of urokinase receptor and caveolin in regulation of integrin signaling. Thromb Haemost 1999;82:291-7
   PubMed Web of Science ®Google Scholar
• Porter JC, Hogg N. Integrins take partners: cross-talk between integrins and other membrane receptors. Trends Cell Biol 1998;8:390-6
   PubMed Web of Science ®Google Scholar
• Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005;6:801-11
   PubMed Web of Science ®Google Scholar
• Del Pozo MA, Schwartz MA. Rac, membrane heterogeneity, caveolin and regulation of growth by integrins. Trends Cell Biol 2007;17:246-50
   PubMed Web of Science ®Google Scholar
• Cox D, Brennan M, Moran N. Integrins as therapeutic targets: lessons and opportunities. Nat Rev Drug Discov 2010;9:804-20
   PubMed Web of Science ®Google Scholar
• Stipp CS. Laminin-binding integrins and their tetraspanin partners as potential antimetastatic targets. Expert Rev Mol Med 2010;12(e3): published online 18 January 2010; doi: 10.1017/S1462399409001355
   PubMedGoogle Scholar
• Mitchell K, Svenson KB, Longmate WM, Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells. Cancer Res 2010;70:6359-67
   PubMedGoogle Scholar
• Chung J, Mercurio AM. Contributions of the alpha6 integrins to breast carcinoma survival and progression. Mol Cells 2004;17:203-9
   PubMed Web of Science ®Google Scholar
• Wang H, Fu W, Im JH, Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol 2004;164:935-41
   PubMedGoogle Scholar
• Yang XH, Richardson AL, Torres-Arzayus MI, CD151 accelerates breast cancer by regulating alpha6 integrin function, signaling, and molecular organization. Cancer Res 2008;68:3204-13
   PubMed Web of Science ®Google Scholar
• Ramirez NE, Zhang Z, Madamanchi A, The alpha2beta1 integrin is a metastasis suppressor in mouse models and human cancer. J Clin Invest 2011;121:226-37
   PubMed Web of Science ®Google Scholar
• Kreidberg JA. Functions of alpha3beta1 integrin. Curr Opin Cell Biol 2000;12:548-53
   PubMed Web of Science ®Google Scholar
• Miyazaki K. Laminin-5 (laminin-332): unique biological activity and role in tumor growth and invasion. Cancer Sci 2006;97:91-8
   PubMedGoogle Scholar
• Chia J, Kusuma N, Anderson R, Evidence for a role of tumor-derived laminin-511 in the metastatic progression of breast cancer. Am J Pathol 2007;170:2135-48
   Google Scholar
• Marinkovich MP. Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 2007;7:370-80
   PubMed Web of Science ®Google Scholar
• DiPersio CM, Hodivala-Dilke KM, Jaenisch R, alpha3beta1 Integrin is required for normal development of the epidermal basement membrane. J Cell Biol 1997;137:729-42
   PubMed Web of Science ®Google Scholar
• Conti FJ, Rudling RJ, Robson A, Hodivala-Dilke KM. alpha3beta1-integrin regulates hair follicle but not interfollicular morphogenesis in adult epidermis. J Cell Sci 2003;116:2737-47
   PubMedGoogle Scholar
• Mitchell K, Szekeres C, Milano V, alpha3beta1 integrin in epidermis promotes wound angiogenesis and keratinocyte-to-endothelial-cell crosstalk through the induction of MRP3. J Cell Sci 2009;122:1778-87
   PubMedGoogle Scholar
• Kreidberg JA, Donovan MJ, Goldstein SL, Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis. Development 1996;122:3537-47
   PubMed Web of Science ®Google Scholar
• Gould VE, Koukoulis GK, Virtanen I. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast. Cell Differ Dev 1990;32:409-16
   PubMedGoogle Scholar
• Koukoulis GK, Virtanen I, Korhonen M, Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules. Am J Pathol 1991;139:787-99
   PubMed Web of Science ®Google Scholar
• Naylor MJ, Li N, Cheung J, Ablation of beta1 integrin in mammary epithelium reveals a key role for integrin in glandular morphogenesis and differentiation. J Cell Biol 2005;171:717-28
   PubMed Web of Science ®Google Scholar
• Taddei I, Deugnier MA, Faraldo MM, beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 2008;10:716-22
   PubMed Web of Science ®Google Scholar
• Klinowska TC, Alexander CM, Georges-Labouesse E, Epithelial development and differentiation in the mammary gland is not dependent on alpha3 or alpha6 integrin subunits. Dev Biol 2001;233:449-67
   PubMedGoogle Scholar
• Jonjic N, Lucin K, Krstulja M, Expression of beta-1 integrins on tumor cells of invasive ductal breast carcinoma. Pathol Res Pract 1993;189:979-84
   PubMed Web of Science ®Google Scholar
• Yao ES, Zhang H, Chen YY, Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007;67:659-64
   PubMed Web of Science ®Google Scholar
• Morini M, Mottolese M, Ferrari N, The alpha3beta1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 2000;87:336-42
   PubMedGoogle Scholar
• Janes SM, Watt FM. Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol 2004;166:419-31
   PubMedGoogle Scholar
• Tawil NJ, Gowri V, Djoneidi M, Integrin alpha3beta1 can promote adhesion and spreading of metastatic breast carcinoma cells on the lymph node stroma. Int J Cancer 1996;66:703-10
   PubMed Web of Science ®Google Scholar
• Lundstrom A, Holmbom J, Lindqvist C, Nordstrom T. The role of alpha2beta1 and alpha3beta1 integrin receptors in the initial anchoring of MDA-MB-231 human breast cancer cells to cortical bone matrix. Biochem Biophys Res Commun 1998;250:735-40
   PubMedGoogle Scholar
• Bergers G, Brekken R, McMahon G, Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-44
   PubMed Web of Science ®Google Scholar
• McCawley LJ, Matrisian LM. Tumor progression: defining the soil round the tumor seed. Curr Biol 2001;11:R25-7
   PubMed Web of Science ®Google Scholar
• Beliveau A, Mott JD, Lo A, Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo. Genes Dev 2010;24:2800-11
   PubMed Web of Science ®Google Scholar
• Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000;103:481-90
   PubMed Web of Science ®Google Scholar
• Lamar JM, Pumiglia KM, DiPersio CM. An immortalization-dependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion. Cancer Res 2008;68:7371-9
   PubMed Web of Science ®Google Scholar
• DiPersio CM, Shao M, Di Costanzo L, Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B. J Cell Sci 2000;113:2909-21
   PubMedGoogle Scholar
• Iyer V, Pumiglia K, DiPersio CM. alpha3beta1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression. J Cell Sci 2005;118:1185-95
   PubMed Web of Science ®Google Scholar
• Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295:2387-92
   PubMed Web of Science ®Google Scholar
• Sehgal I, Thompson TC. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol Biol Cell 1999;10:407-16
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Munshi HG, Kambhampati S, Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma. J Biol Chem 2004;279:33139-46
   PubMedGoogle Scholar
• Howe LR, Chang SH, Tolle KC, HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res 2005;65:10113-19
   PubMed Web of Science ®Google Scholar
• Stasinopoulos I, O'Brien DR, Wildes F, Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells. Mol Cancer Res 2007;5:435-42
   Google Scholar
• Liu CH, Chang SH, Narko K, Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001;276:18563-9
   PubMed Web of Science ®Google Scholar
• Howe LR. Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res 2007;9:210-18
   PubMed Web of Science ®Google Scholar
• Singh-Ranger G, Salhab M, Mokbel K. The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res Treat 2008;109:189-98
   PubMed Web of Science ®Google Scholar
• Harris RE. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 2009;17:55-67
   PubMedGoogle Scholar
• Chan AT, Ogino S, Fuchs CS. Aspirin use and survival after diagnosis of colorectal cancer. JAMA 2009;302:649-58
   PubMed Web of Science ®Google Scholar
• Holmes MD, Chen WY, Li L, Aspirin intake and survival after breast cancer. J Clin Oncol 2010;28:1467-72
   PubMed Web of Science ®Google Scholar
• Baron JA, Sandler RS, Bresalier RS, Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 2008;372:1756-64
   PubMed Web of Science ®Google Scholar
• Marnett LJ. The COXIB experience: a look in the rearview mirror. Annu Rev Pharmacol Toxicol 2009;49:265-90
   PubMed Web of Science ®Google Scholar
• Carpenter PM, Dao AV, Arain ZS, Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5). Mol Cancer Res 2009;7:462-75
   PubMed Web of Science ®Google Scholar
• Ghosh S, Johnson JJ, Sen R, Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways. J Biol Chem 2006;281:13021-9
   PubMed Web of Science ®Google Scholar
• Sugiura T, Berditchevski F. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 1999;146:1375-89
   PubMedGoogle Scholar
• Yauch RL, Berditchevski F, Harler MB, Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration. Mol Biol Cell 1998;9:2751-65
   PubMed Web of Science ®Google Scholar
• Wei Y, Eble JA, Wang Z, Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol Biol Cell 2001;12:2975-86
   PubMed Web of Science ®Google Scholar
• Novitskaya V, Romanska H, Dawoud M, Tetraspanin CD151 regulates growth of mammary epithelial cells in three-dimensional extracellular matrix: implication for mammary ductal carcinoma in situ. Cancer Res 2010;70:4698-708
   Google Scholar
• Sadej R, Romanska H, Baldwin G, CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium. Mol Cancer Res 2009;7:787-98
   PubMed Web of Science ®Google Scholar
• Zijlstra A, Lewis J, Degryse B, The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 2008;13:221-34
   PubMed Web of Science ®Google Scholar
• Sadej R, Romanska H, Kavanagh D, Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis. Cancer Res 2010;70:6059-70
   PubMed Web of Science ®Google Scholar
• Yang XH, Flores LM, Li Q, Disruption of laminin-integrin-CD151-focal adhesion kinase axis sensitizes breast cancer cells to ErbB2 antagonists. Cancer Res 2010;70:2256-63
   Google Scholar
• Baldwin G, Novitskaya V, Sadej R, Tetraspanin CD151 regulates glycosylation of alpha3beta1 integrin. J Biol Chem 2008;283:35445-54
   PubMed Web of Science ®Google Scholar
• Zevian S, Winterwood NE, Stipp CS. Structure-function analysis of tetraspanin CD151 teveals distinct requirements for tumor cell behaviors mediated by alpha3beta1 versus alpha6beta4 integrin. J Biol Chem 2011;286:7496-506
   PubMed Web of Science ®Google Scholar
• Nishiuchi R, Sanzen N, Nada S, Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151. Proc Natl Acad Sci USA 2005;102:1939-44
   PubMed Web of Science ®Google Scholar
• Lammerding J, Kazarov AR, Huang H, Tetraspanin CD151 regulates alpha6beta1 integrin adhesion strengthening. Proc Natl Acad Sci USA 2003;100:7616-21
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Wang Z, Ashman LK, alpha3beta1 integrin-CD151, a component of the cadherin-catenin complex, regulates PTPmu expression and cell-cell adhesion. J Cell Biol 2003;163:1351-62
   PubMed Web of Science ®Google Scholar
• Tang CH, Wei Y. The urokinase receptor and integrins in cancer progression. Cell Mol Life Sci 2008;65:1916-32
   PubMedGoogle Scholar
• Ghosh S, Koblinski J, Johnson J, Urinary-type plasminogen activator receptor/alpha3beta1 integrin signaling, altered gene expression, and oral tumor progression. Mol Cancer Res 2010;8:145-58
   PubMedGoogle Scholar
• van der Pluijm G, Sijmons B, Vloedgraven H, Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. Am J Pathol 2001;159:971-82
   PubMed Web of Science ®Google Scholar
• Carriero MV, Del Vecchio S, Capozzoli M, Urokinase receptor interacts with alphavbeta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res 1999;59:5307-14
   PubMedGoogle Scholar
• Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9
   PubMed Web of Science ®Google Scholar
• Chang SH, Liu CH, Conway R, Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci USA 2004;101:591-6
   PubMed Web of Science ®Google Scholar
• Akool el S, Kleinert H, Hamada FM, Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol Cell Biol 2003;23:4901-16
   PubMedGoogle Scholar
• Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life Sci 2001;58:266-77
   PubMed Web of Science ®Google Scholar
• Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 1994;9:1925-9
   PubMedGoogle Scholar
• Dixon DA, Tolley ND, King PH, Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 2001;108:1657-65
   PubMed Web of Science ®Google Scholar
• Subbaram S, Kuentzel M, Frank D, Determination of alternate splicing events using the Affymetrix Exon 1.0 ST arrays. Methods Mol Biol 2010;632:63-72
   PubMedGoogle Scholar
• Winzen R, Kracht M, Ritter B, The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J 1999;18:4969-80
   PubMed Web of Science ®Google Scholar
• Pages G, Berra E, Milanini J, Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. J Biol Chem 2000;275:26484-91
   PubMed Web of Science ®Google Scholar
• Yang X, Wang W, Fan J, Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR. J Biol Chem 2004;279:49298-306
   PubMed Web of Science ®Google Scholar
• Lasa M, Mahtani KR, Finch A, Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 2000;20:4265-74
   PubMedGoogle Scholar
• Montero L, Nagamine Y. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. Cancer Res 1999;59:5286-93
   PubMed Web of Science ®Google Scholar
• Han Q, Leng J, Bian D, Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells. J Biol Chem 2002;277:48379-85
   PubMedGoogle Scholar
• Bromann PA, Korkaya H, Webb CP, Platelet-derived growth factor stimulates Src-dependent mRNA stabilization of specific early genes in fibroblasts. J Biol Chem 2005;280:10253-63
   PubMed Web of Science ®Google Scholar
• Choma DP, Pumiglia K, DiPersio CM. Integrin alpha3beta1 directs the stabilization of a polarized lamellipodium in epithelial cells through activation of Rac1. J Cell Sci 2004;117:3947-59
   PubMedGoogle Scholar
• Fernau NS, Fugmann D, Leyendecker M, Role of HuR and p38MAPK in ultraviolet B-induced post-transcriptional regulation of COX-2 expression in the human keratinocyte cell line HaCaT. J Biol Chem 2010;285:3896-904
   PubMedGoogle Scholar
• Dixon DA, Kaplan CD, McIntyre TM, Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem 2000;275:11750-7
   PubMed Web of Science ®Google Scholar
• Malyankar UM, Rittling SR, Connor A, Denhardt DT. The mitogen-regulated protein/proliferin transcript is degraded in primary mouse embryo fibroblast but not 3T3 nuclei: altered RNA processing correlates with immortalization. Proc Natl Acad Sci USA 1994;91:335-9
   PubMedGoogle Scholar
• Winterwood NE, Varzavand A, Meland MN, A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5. Mol Biol Cell 2006;17:2707-21
   PubMed Web of Science ®Google Scholar
• Shang M, Koshikawa N, Schenk S, Quaranta V. The LG3 module of laminin-5 harbors a binding site for integrin alpha3beta1 that promotes cell adhesion, spreading, and migration. J Biol Chem 2001;276:33045-53
   PubMed Web of Science ®Google Scholar
• Kunneken K, Pohlentz G, Schmidt-Hederich A, Recombinant human laminin-5 domains. Effects of heterotrimerization, proteolytic processing, and N-glycosylation on alpha3beta1 integrin binding. J Biol Chem 2004;279:5184-93
   PubMedGoogle Scholar
• Zhang XP, Puzon-McLaughlin W, Irie A, alpha3beta1 adhesion to laminin-5 and invasin: critical and differential role of integrin residues clustered at the boundary between alpha3 N-terminal repeats 2 and 3. Biochemistry 1999;38:14424-31
   PubMed Web of Science ®Google Scholar
• Krukonis ES, Dersch P, Eble JA, Isberg RR. Differential effects of integrin alpha chain mutations on invasin and natural ligand interaction. J Biol Chem 1998;273:31837-43
   PubMedGoogle Scholar
• Nabors LB, Mikkelsen T, Rosenfeld SS, Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma. J Clin Oncol 2007;25:1651-7
   PubMed Web of Science ®Google Scholar
• Reynolds AR, Hart IR, Watson AR, Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat Med 2009;15:392-400
   PubMed Web of Science ®Google Scholar
• da Silva RG, Tavora B, Robinson SD, Endothelial alpha3beta1 integrin represses pathological angiogenesis and sustains endothelial-VEGF. Am J Pathol 2010;177:1534-48
   PubMedGoogle Scholar
• Alexis F, Rhee JW, Richie JP, New frontiers in nanotechnology for cancer treatment. Urol Oncol 2008;26:74–85
   PubMed Web of Science ®Google Scholar